Osmoprotective transcription factor NFAT5/TonEBP modulates nuclear factor-κB activity

Molecular Biology of the Cell

Volumn 21, Issue 19, 2010, Pages 3459-3474

  Roth, Isabelle ^a   Leroy, Valérie ^a   Kwon, H Moo ^a   Martin, Pierre Yves ^a   Féraille, Eric ^a   Hasler, Udo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTONIC SOLUTION; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT5; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CELL NUCLEUS; HEP G2 CELLS; HUMANS; HYPERTONIC SOLUTIONS; I-KAPPA B PROTEINS; MACROPHAGES; MODELS, BIOLOGICAL; NF-KAPPA B; OSMOSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77958055648     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-02-0133     Document Type: Article

References (72)

1. Andrieu, N., Salvayre, R., Jaffrezou, J. P., and Levade, T. (1995). Low temperatures and hypertonicity do not block cytokine-induced stimulation of the sphingomyelin pathway but inhibit nuclear factor-kappa B activation. J. Biol. Chem. 270, 24518-24524.
2. Biswas, D. K., and Iglehart, J. D. (2006). Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer. J. Cell. Physiol. 209, 645-652.
3. Bonnard, M., et al. (2000). Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J. 19, 4976-4985.
4. Burg, M., Ferraris, J., and Dmitrieva, N. (2007). Cellular response to hypertonic stress. Physiol. Rev. 87, 1441-1474.
5. Canono, B. P., and Campbell, P. A. (1992). Production of mouse inflammatory macrophage hybridomas. J. Tissue Cult. Methods 14, 3-8.
6. Citri, A., and Yarden, Y. (2006). EGF-ERBB signalling: towards the systems level. Nat. Rev. Mol. Cell Biol. 7, 505-516.
7. Deng, W. G., Zhu, Y., Montero, A., and Wu, K. K. (2003). Quantitative analysis of binding of transcription factor complex to biotinylated DNA probe by a streptavidin-agarose pulldown assay. Anal. Biochem. 323, 12-18.
8. Esensten, J. H., Tsytsykova, A. V., Lopez-Rodriguez, C., Ligeiro, F. A., Rao, A., and Goldfeld, A. E. (2005). NFAT5 binds to the TNF promoter distinctly from NFATp, c, 3 and 4, and activates TNF transcription during hypertonic stress alone. Nucleic Acids Res. 33, 3845-3854.
9. Fujita, T., Nolan, G. P., Liou, H. C., Scott, M. L., and Baltimore, D. (1993). The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes Dev. 7, 1354-1363.
10. Gaeggeler, H. P., Gonzalez-Rodriguez, E., Jaeger, N. F., Loffing-Cueni, D., Norregaard, R., Loffing, J., Horisberger, J. D., and Rossier, B. C. (2005). Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line. J. Am. Soc. Nephrol. 16, 878-891.
11. Go, W. Y., Liu, X., Roti, M. A., Liu, F., and Ho, S. N. (2004). NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. Proc. Natl. Acad. Sci. USA 101, 10673-10678.
12. Granic, I., Dolga, A. M., Nijholt, I. M., van Dijk, G., and Eisel, U. L. (2009). Inflammation and NF-kappaB in Alzheimer's disease and diabetes. J. Alzheimers Dis. 16, 809-821.
13. Gum, R. J., McLaughlin, M. M., Kumar, S., Wang, Z., Bower, M. J., Lee, J. C., Adams, J. L., Livi, G. P., Goldsmith, E. J., and Young, P. R. (1998). Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J. Biol. Chem. 273, 15605-15610.
14. Hao, C. M., Yull, F., Blackwell, T., Komhoff, M., Davis, L. S., and Breyer, M. D. (2000). Dehydration activates an NF-kappaB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells. J. Clin. Invest. 106, 973-982.
15. Hao, S., Zhao, H., Darzynkiewicz, Z., Battula, S., and Ferreri, N. R. (2009). Expression and function of NFAT5 in medullary thick ascending limb (mTAL) cells. Am. J. Physiol. Renal Physiol. 296, F1494-F1503.
16. Hasler, U., Jeon, U. S., Kim, J. A., Mordasini, D., Kwon, H. M., Feraille, E., and Martin, P. Y. (2006a). Tonicity-responsive enhancer binding protein is an essential regulator of aquaporin-2 expression in renal collecting duct principal cells. J. Am. Soc. Nephrol. 17, 1521-1531.
17. Hasler, U., Leroy, V., Jeon, U. S., Bouley, R., Dimitrov, M., Kim, J. A., Brown, D., Kwon, H. M., Martin, P. Y., and Feraille, E. (2008). NF-kappa B modulates aquaporin-2 transcription in renal collecting duct principal cells. J. Biol. Chem. 283, 28095-28105.
18. Hasler, U., Nielsen, S., Feraille, E., and Martin, P. Y. (2006b). Posttranscriptional control of aquaporin-2 abundance by vasopressin in renal collecting duct principal cells. Am. J. Physiol. Renal Physiol. 290, F177-F187.
19. Hasler, U., Vinciguerra, M., Vandewalle, A., Martin, P.-Y., and Feraille, E. (2005). Dual effects of hypertonicity on aquaporin-2 expression in cultured renal collecting duct principal cells. J. Am. Soc. Nephrol. 16, 1571-1582.
20. Hattori, Y., Hattori, S., Sato, N., and Kasai, K. (2000). High-glucose-induced nuclear factor kappaB activation in vascular smooth muscle cells. Cardiovasc. Res. 46, 188-197.
21. Hayden, M. S., and Ghosh, S. (2004). Signaling to NF-kappaB. Genes Dev. 18, 2195-2224.
22. Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M. S., Jin, O., and Woodgett, J. R. (2000). Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406, 86-90.
23. Irarrazabal, C. E., Burg, M. B., Ward, S. G., and Ferraris, J. D. (2006). Phosphatidylinositol 3-kinase mediates activation ofATMby high NaCl and by ionizing radiation: role in osmoprotective transcriptional regulation. Proc. Natl. Acad. Sci. USA 103, 8882-8887.
24. Irarrazabal, C. E., Liu, J. C., Burg, M. B., and Ferraris, J. D. (2004). ATM, a DNA damage-inducible kinase, contributes to activation by high NaCl of the transcription factor TonEBP/OREBP. Proc. Natl. Acad. Sci. USA 101, 8809-8814.
25. Irarrazabal, C. E., Williams, C. K., Ely, M. A., Birrer, M. J., Garcia-Perez, A., Burg, M. B., and Ferraris, J. D. (2008). Activator protein-1 contributes to high NaCl-induced increase in tonicity-responsive enhancer/osmotic response element-binding protein transactivating activity. J. Biol. Chem. 283, 2554-2563.
26. Kane, L. P., Mollenauer, M. N., Xu, Z., Turck, C. W., and Weiss, A. (2002). Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription. Mol. Cell. Biol. 22, 5962-5974.
27. Kim, H., Seo, J. Y., and Kim, K. H. (1999). Effects of mannitol and dimethylthiourea on Helicobacter pylori-induced IL-8 production in gastric epithelial cells. Pharmacology 59, 201-211.
28. King, E. M., Holden, N. S., Gong, W., Rider, C. F., and Newton, R. (2009). Inhibition of NF-kappaB-dependent transcription by MKP-1, transcriptional repression by glucocorticoids occurring via p38 MAPK. J. Biol. Chem. 284, 26803-26815.
29. Ko, B. C., Lam, A. K., Kapus, A., Fan, L., Chung, S. K., and Chung, S. S. (2002). Fyn and p38 signaling are both required for maximal hypertonic activation of the osmotic response element-binding protein/tonicity-responsive enhancer-binding protein (OREBP/TonEBP). J. Biol. Chem. 277, 46085-46092.
30. Kolsen-Petersen, J. A. (2004). Immune effect of hypertonic saline: fact or fiction? Acta Anaesthesiol. Scand. 48, 667-678.
31. Kultz, D., Garcia-Perez, A., Ferraris, J. D., and Burg, M. B. (1997). Distinct regulation of osmoprotective genes in yeast and mammals. Aldose reductase osmotic response element is induced independent of p38 and stress-activated protein kinase/Jun N-terminal kinase in rabbit kidney cells. J. Biol. Chem. 272, 13165-13170.
32. Kuper, C., Steinert, D., Fraek, M. L., Beck, F. X., and Neuhofer, W. (2009). EGF receptor signaling is involved in expression of osmoprotective TonEBP target gene aldose reductase under hypertonic conditions. Am. J. Physiol. Renal Physiol. 296, F1100-F1108.
33. Kwon, H. M., Itoh, T., Rim, J. S., and Handler, J. S. (1995). The MAP kinase cascade is not essential for transcriptional stimulation of osmolyte transporter genes. Biochem. Biophys. Res. Commun. 213, 975-979.
34. Kwon, M. S., Lim, S. W., and Kwon, H. M. (2009). Hypertonic stress in the kidney: a necessary evil. Physiology 24, 186-191.
35. Lamitina, T., Huang, C. G., and Strange, K. (2006). Genome-wide RNAi screening identifies protein damage as a regulator of osmoprotective gene expression. Proc. Natl. Acad. Sci. USA 103, 12173-12178.
36. Lee, J. H., Kim, M., Im, Y. S., Choi, W., Byeon, S. H., and Lee, H. K. (2008). NFAT5 induction and its role in hyperosmolar stressed human limbal epithelial cells. Invest. Ophthalmol. Vis. Sci. 49, 1827-1835.
37. Leroy, V., de Seigneux, S., Agassiz, V., Hasler, U., Rafestin-Oblin, M.-E., Vinciguerra, M., Martin, P. Y., and Feraille, E. (2007). Aldosterone activates NF-κB in the collecting duct. J. Am. Soc. Nephrol. 20, 131-144.
38. Li, J. J., Cao, Y., Young, M. R., and Colburn, N. H. (2000). Induced expression of dominant-negative c-jun downregulates NFkappaB and AP-1 target genes and suppresses tumor phenotype in human keratinocytes. Mol. Carcinog. 29, 159-169.
39. Lopez-Rodriguez, C., Aramburu, J., Jin, L., Rakeman, A. S., Michino, M., and Rao, A. (2001). Bridging the NFAT and NF-kappaB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress. Immunity 15, 47-58.
40. Machnik, A., et al. (2009). Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat. Med. 15, 545-552.
41. Madrid, L. V., Wang, C. Y., Guttridge, D. C., Schottelius, A. J., Baldwin, A. S., Jr., and Mayo, M. W. (2000). Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol. Cell. Biol. 20, 1626-1638.
42. Maouyo, D., Kim, J. Y., Lee, S. D., Wu, Y., Woo, S. K., and Kwon, H. M. (2002). Mouse TonEBP-NFAT 5, expression in early development and alternative splicing. Am. J. Physiol. Renal Physiol. 282, F802-F809.
43. Mattson, M. P., and Meffert, M. K. (2006). Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ. 13, 852-860.
44. Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J., Young, D. B., Barbosa, M., Mann, M., Manning, A., and Rao, A. (1997). IKK-1 and IKK-2, cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278, 860-866.
45. Miyakawa, H., Woo, S. K., Chen, C. P., Dahl, S. C., Handler, J. S., and Kwon, H. M. (1998). Cis- and trans-acting factors regulating transcription of the BGT1 gene in response to hypertonicity. Am. J. Physiol. Renal Physiol. 274, F753-F761.
46. Mordasini, D., Bustamante, M., Rousselot, M., Martin, P. Y., Hasler, U., and Feraille, E. (2005). Stimulation of Na+ transport by AVP is independent of PKA phosphorylation of the Na-K-ATPase in collecting duct principal cells. Am. J. Physiol. Renal Physiol. 289, F1031-F1039.
47. Nadkarni, V., Gabbay, K. H., Bohren, K. M., and Sheikh-Hamad, D. (1999). Osmotic response element enhancer activity. Regulation through p38 kinase and mitogen-activated extracellular signal-regulated kinase kinase. J. Biol. Chem. 274, 20185-20190.
48. Nahm, O., Woo, S. K., Handler, J. S., and Kwon, H. M. (2002). Involvement of multiple kinase pathways in stimulation of gene transcription by hypertonicity. Am. J. Physiol. Cell Physiol. 282, C49-C58.
49. Nicholson, K. M., and Anderson, N. G. (2002). The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal. 14, 381-395.
50. Oyama, T., Ran, S., Ishida, T., Nadaf, S., Kerr, L., Carbone, D. P., and Gabrilovich, D. I. (1998). Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J. Immunol. 160, 1224-1232.
51. Ozes, O. N., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., and Donner, D. B. (1999). NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401, 82-85.
52. Pingle, S. C., Sanchez, J. F., Hallam, D. M., Williamson, A. L., Maggirwar, S. B., and Ramkumar, V. (2003). Hypertonicity inhibits lipopolysaccharide-induced nitric oxide synthase expression in smooth muscle cells by inhibiting nuclear factor kappaB. Mol. Pharmacol. 63, 1238-1247.
53. Rangan, G., Wang, Y., and Harris, D. (2009). NF-kappaB signalling in chronic kidney disease. Front. Biosci. 14, 3496-3522.
54. Razani, B., Chakravarthy, M. V., and Semenkovich, C. F. (2008). Insulin resistance and atherosclerosis. Endocrinol. Metab. Clin. North Am. 37, 603-621, viii.
55. Rohlfing, A. K., Miteva, Y., Hannenhalli, S., and Lamitina, T. (2010) Genetic and physiological activation of osmosensitive gene expression mimics transcriptional signatures of pathogen infection in C. elegans. PLoS One 5, e9010.
56. Romashkova, J. A., and Makarov, S. S. (1999). NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401, 86-90.
57. Rosette, C., and Karin, M. (1996). Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274, 1194-1197.
58. Sethi, G., Ahn, K. S., Chaturvedi, M. M., and Aggarwal, B. B. (2007). Epidermal growth factor (EGF) activates nuclear factor-kappaB through IkappaBalpha kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IkappaBalpha. Oncogene 26, 7324-7332.
59. Shapiro, L., and Dinarello, C. A. (1997). Hyperosmotic stress as a stimulant for proinflammatory cytokine production. Exp. Cell Res. 231, 354-362.
60. Sheikh-Hamad, D., and Gustin, M. C. (2004). MAP kinases and the adaptive response to hypertonicity: functional preservation from yeast to mammals. Am. J. Physiol. Renal Physiol. 287, F1102-F1110.
61. Simmonds, R. E., and Foxwell, B. M. (2008). Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation. Rheumatology 47, 584-590.
62. Stein, B., Baldwin, A. S., Jr., Ballard, D. W., Greene, W. C., Angel, P., and Herrlich, P. (1993). Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12, 3879-3891.
63. Sun, L., and Carpenter, G. (1998). Epidermal growth factor activation of NF-kappaB is mediated through IkappaBalpha degradation and intracellular free calcium. Oncogene 16, 2095-2102.
64. Thomas, R. S., Tymms, M. J., McKinlay, L. H., Shannon, M. F., Seth, A., and Kola, I. (1997). ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter. Oncogene 14, 2845-2855.
65. Tsai, P. W., Shiah, S. G., Lin, M. T., Wu, C. W., and Kuo, M. L. (2003). Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J. Biol. Chem. 278, 5750-5759.
66. Vallabhapurapu, S., and Karin, M. (2009). Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693-733.
67. Vinciguerra, M., Carrozzino, F., Peyrou, M., Carlone, S., Montesano, R., Benelli, R., and Foti, M. (2009). Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN. J. Hepatol. 50, 1132-1141.
68. Vinciguerra, M., Hasler, U., Mordasini, D., Roussel, M., Capovilla, M., Ogier-Denis, E., Vandewalle, A., Martin, P. Y., and Feraille, E. (2005). Cytokines and sodium induce protein kinase A-dependent cell-surface Na,K-ATPase recruitment via dissociation of NF-{kappa}B/I{kappa}B/protein kinase A catalytic subunit complex in collecting duct principal Cells. J. Am. Soc. Nephrol. 16, 2576-2585.
69. Xiao, W., Hodge, D. R., Wang, L., Yang, X., Zhang, X., and Farrar, W. L. (2004). NF-kappaB activates IL-6 expression through cooperation with c-Jun and IL6-AP1 site, but is independent of its IL6-NFkappaB regulatory site in autocrine human multiple myeloma cells. Cancer Biol. Ther. 3, 1007-1017.
70. Zhong, H., SuYang, H., Erdjument-Bromage, H., Tempst, P., and Ghosh, S. (1997). The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89, 413-424.
71. Zhou, X., Ferraris, J. D., Dmitrieva, N. I., Liu, Y., and Burg, M. B. (2008). MKP-1 inhibits high NaCl-induced activation of p38 but does not inhibit the activation of TonEBP/OREBP: opposite roles of p38alpha and p38delta. Proc. Natl. Acad. Sci. USA 105, 5620-5625.
72. Zhou, X., Gallazzini, M., Burg, M. B., and Ferraris, J. D. (2010). Contribution of SHP-1 protein tyrosine phosphatase to osmotic regulation of the transcription factor TonEBP/OREBP. Proc. Natl. Acad. Sci. USA 107, 7072-7077.